Concurrent vaccination against equine influenza and equine herpesvirus – a practical approach

Influenza and other Respiratory Viruses

Volumn 10, Issue 5, 2016, Pages 433-437

  Gildea, Sarah ^a   Sanchez Higgins, Maria Jose ^b   Johnson, Gillian ^a   Walsh, Cathal ^c   Cullinane, Ann ^a  

^a IRISH EQUINE CENTRE   (Ireland)

^b Newbridge Co   (Ireland)

^c UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Concurrent; herpesvirus; influenza; racehorse; vaccination

Indexed keywords

EQUINE HERPESVIRUS VACCINE; EQUINE INFLUENZA VACCINE; INACTIVATED VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG SAFETY; EQUID HERPESVIRUS 4; EQUINE HERPESVIRUS 1 INFECTION; EQUINE HERPESVIRUS 4 INFECTION; EQUINE INFLUENZA; HEMOLYSIS; HERPES VIRUS INFECTION; HUMORAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; THOROUGHBRED HORSE; VACCINATION;

EID: 84978764128     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12396     Document Type: Article

References (17)

1. Gildea S, Arkins S, Cullinane A. Management and environmental factors involved in equine influenza outbreaks in Ireland 2007-2010. Equine Vet J 2011; 43:608–617.
2. Gildea S, Fitzpatrick DA, Cullinane A. Epidemiological and virological investigations of equine influenza outbreaks in Ireland (2010-2012). Influenza Other Respi Viruses 2013; 4:61–72.
3. Woodward AL, Rash AS, Blinman D et al. Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010-2012. Vet Microbiol 2014; 169:113–127.
4. Gilkerson JR, Whalley JM, Drummer HE, Studdert MJ, Love DN. Epidemiological studies of equine herpesvirus 1 (EHV-1) in Thoroughbred foals: a review of studies conducted in the Hunter Valley of New South Wales between 1995 and 1997. Vet Microbiol 1999; 68:15–25.
5. Doll ER, Bryans JT. Immunization of young horses against viral rhinopneumonitis. Cornell Vet 1963; 53:24–41.
6. Newton JR, Townsend HG, Wood JL, Sinclair R, Hannant D, Mumford JA. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet J 2000; 32:65–74.
7. Mumford JA, Wilson H, Hannant D, Jessett DM. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol Infect 1994; 112:421–437.
8. Mumford JA. Biology, epidemiology and vaccinology of equine influenza. Proceedings of the International Symposium, Budapest 2001; 10–11:7–12.
9. Goehring LS, Wagner B, Bigbie R et al. Control of EHV-1 viremia and nasal shedding by commercial vaccines. Vaccine 2010; 28:5203–5211.
10. Goodman LB, Wagner B, Flaminio MJ et al. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1). Vaccine 2006; 24:3636–3645.
11. Heldens JG, Hannant D, Cullinane AA et al. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares. Vaccine 2001; 19:4307–4317.
12. Gildea S, Arkins S, Cullinane A. A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus. Influenza Other Respi Viruses 2010; 4:363–372.
13. OIE 2014. Manual of diagnostic tests and vaccines for terrestrial animals. Equine Rhinopneumonitis Chapter 2.5.9; 894–903.
14. Heldens JG, Weststrate MW, van den Hoven R. Area under the curve calculations as a tool to compare the efficacy of equine influenza vaccines-a retrospective analysis of three independent field trials. J Immunol Methods 2002; 264:11–17.
15. Gildea S, Arkins S, Walsh C, Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study. Vaccine 2011; 29:3917–3922.
16. Gildea S, Quinlivan M, Murphy BA, Cullinane A. Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings – a blinded comparison of commercially available vaccines. Vaccine 2013; 31:5216–5222.
17. Allen GP, Bryans JT. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Prog Vet Micro Immunol 1986; 2:78–144.